Joel E. Shaffer

533 total citations
20 papers, 427 citations indexed

About

Joel E. Shaffer is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Joel E. Shaffer has authored 20 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Joel E. Shaffer's work include Nitric Oxide and Endothelin Effects (6 papers), Receptor Mechanisms and Signaling (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Joel E. Shaffer is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Receptor Mechanisms and Signaling (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Joel E. Shaffer collaborates with scholars based in United States, United Kingdom and Spain. Joel E. Shaffer's co-authors include Richard J. Gorczynski, Kafait U. Malik, Robert J. Lee, James J. Kocsis, Wendy H. Chern, Mary K. Grizzle, Michael K. James, Christy L. Cooper, Ann M. Vuong and Check Y. Quon and has published in prestigious journals such as Circulation Research, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Joel E. Shaffer

19 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel E. Shaffer United States	12	139	135	89	85	60	20	427
R. A. Ferrone United States	12	94 0.7×	188 1.4×	140 1.6×	26 0.3×	35 0.6×	13	498
C Richer France	16	117 0.8×	395 2.9×	231 2.6×	21 0.2×	54 0.9×	46	737
E Kirsten United States	11	69 0.5×	191 1.4×	88 1.0×	64 0.8×	12 0.2×	18	491
A. Hayes United Kingdom	8	44 0.3×	85 0.6×	162 1.8×	56 0.7×	32 0.5×	15	599
Fumio Takenaka Japan	11	102 0.7×	168 1.2×	105 1.2×	17 0.2×	35 0.6×	55	412
Donald D. Smyth Canada	16	95 0.7×	130 1.0×	230 2.6×	26 0.3×	55 0.9×	45	573
C. W. Loomis Canada	15	187 1.3×	35 0.3×	128 1.4×	23 0.3×	59 1.0×	22	521
M.A. Villalobos Spain	12	63 0.5×	60 0.4×	56 0.6×	19 0.2×	50 0.8×	16	371
J. S. Stephenson United Kingdom	6	52 0.4×	140 1.0×	132 1.5×	26 0.3×	33 0.6×	8	463
Hiroko Hashizume Japan	13	56 0.4×	203 1.5×	249 2.8×	42 0.5×	25 0.4×	41	558

Countries citing papers authored by Joel E. Shaffer

Since Specialization

Citations

This map shows the geographic impact of Joel E. Shaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel E. Shaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel E. Shaffer more than expected).

Fields of papers citing papers by Joel E. Shaffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel E. Shaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel E. Shaffer. The network helps show where Joel E. Shaffer may publish in the future.

Co-authorship network of co-authors of Joel E. Shaffer

This figure shows the co-authorship network connecting the top 25 collaborators of Joel E. Shaffer. A scholar is included among the top collaborators of Joel E. Shaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel E. Shaffer. Joel E. Shaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Shaffer, Joel E., et al.. (2002). Discovery of a Potent and Selective α1A Antagonist. Pharmaceutical biotechnology. 11. 423–443. 1 indexed citations

2.

Shaffer, Joel E., et al.. (1999). Use of “N-in-one” Dosing to Create an in Vivo Pharmacokinetics Database for use in Developing Structure—Pharmacokinetic Relationships. Journal of Pharmaceutical Sciences. 88(3). 313–318. 33 indexed citations

3.

Shaffer, Joel E., et al.. (1993). The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1105–1112. 3 indexed citations

4.

James, Michael K., et al.. (1992). Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 84–91. 48 indexed citations

5.

Shaffer, Joel E., et al.. (1992). Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.. Journal of Pharmacology and Experimental Therapeutics. 260(1). 286–293. 56 indexed citations

6.

Shaffer, Joel E., et al.. (1990). The hemodynamic effects of S-nitrosocaptopril in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 256(2). 704–709. 31 indexed citations

7.

Shaffer, Joel E., Check Y. Quon, & Richard J. Gorczynski. (1988). β-Adrenoreceptor Antagonist Potency and Pharmacodynamics of ASL-8123, the Primary Acid Metabolite of Esmolol. Journal of Cardiovascular Pharmacology. 11(2). 187–192. 13 indexed citations

8.

Shaffer, Joel E., Check Y. Quon, & Richard J. Gorczynski. (1988). β-Adrenoreceptor Antagonist Potency and Pharmacodynamics of ASL-8123, the Primary Acid Metabolite of Esmolol. Journal of Cardiovascular Pharmacology. 11(2). 187–192. 13 indexed citations

9.

Shaffer, Joel E., Ann M. Vuong, & Richard J. Gorczynski. (1986). Participation of the autonomic nervous system in the cardiovascular effects of milrinone. Life Sciences. 38(21). 1967–1974.

10.

Shaffer, Joel E., A. Vuong, Richard J. Gorczynski, & W. L. Matier. (1986). In vitro and in vivo evaluation of two ultrashort‐acting beta‐adrenoreceptor antagonists: ACC‐9129 and ACC‐9369. Drug Development Research. 7(3). 221–232. 1 indexed citations

11.

Brown, Barry S., Richard J. Gorczynski, Robert D. Reynolds, & Joel E. Shaffer. (1986). Comparison of the parasympatholytic activity of ACC‐9358 and disopyramide. British Journal of Pharmacology. 87(1). 87–95. 1 indexed citations

12.

Shaffer, Joel E.. (1985). Inotropic and Chronotropic Activity of Berberine on Isolated Guinea Pig Atria. Journal of Cardiovascular Pharmacology. 7(2). 307–315. 30 indexed citations

13.

Cooper, Christy L., Joel E. Shaffer, & Kafait U. Malik. (1985). Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of Ca++ antagonists and calmodulin inhibitors.. Circulation Research. 56(1). 97–108. 29 indexed citations

14.

Shaffer, Joel E. & Richard J. Gorczynski. (1985). Role of alpha-adrenergic receptors in the intrinsic inotropic selectivity of dobutamine in anesthetized dogs. Canadian Journal of Physiology and Pharmacology. 63(6). 630–635. 3 indexed citations

15.

Shaffer, Joel E. & Kafait U. Malik. (1984). Mechanism of action of arachidonic acid in the isolated perfused rat heart. Canadian Journal of Physiology and Pharmacology. 62(5). 551–558. 12 indexed citations

16.

Gorczynski, Richard J., Joel E. Shaffer, & Robert J. Lee. (1983). Pharmacology of ASL-8052, a Novel β-Adrenergic Receptor Antagonist with an Ultrashort Duration of Action. Journal of Cardiovascular Pharmacology. 5(4). 668–677. 69 indexed citations

17.

Shaffer, Joel E. & Kafait U. Malik. (1982). Enhancement of prostaglandin output during activation of beta-1 adrenoceptors in the isolated rabbit heart.. Journal of Pharmacology and Experimental Therapeutics. 223(3). 729–735. 30 indexed citations

18.

Shaffer, Joel E., Lauren M. Cagen, & Kafait U. Malik. (1981). Attenuation by acetaminophen of arachidonic acid-induced coronary vasolidation and output of prostaglandins in the isolated rat heart. European Journal of Pharmacology. 72(1). 57–61. 7 indexed citations

19.

Shaffer, Joel E. & James J. Kocsis. (1981). Taurine mobilizing effects of beta alanine and other inhibitors of taurine transport. Life Sciences. 28(24). 2727–2736. 46 indexed citations

20.

Shaffer, Joel E.. (1979). The effect of beta alanine and other inhibitors of taurine transport on taurine disposition. The Medicine Forum. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact